Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/148013| Title: | Peer Review, Peer Education, and Modeling in the Practice of Clinical Ethics Consultation: The Zadeh Project |
| Authors: | Finder, Stuart G. Bliton, Mark J. |
| Issue Date: | 2018 |
| Publisher: | Springer |
| link: | https://library.oapen.org/bitstream/20.500.12657/22936/1/1007225.pdf |
| Keywords: | Medicine;cinnamic acid derivatives;soybean seed ferritin;iron release;binding ability;Fe2+-chelating activity;reducibility;adverse event profile;anaemia;bioengineering;labile iron;intravenous iron;iron-carbohydrate complex;iron processing;iron metabolism;infection;innate immunity;hepcidin;ferritin;anemia of inflammation;pharmaceutical targets;iron deficiency anemia;nutrient iron;oral iron therapy;FeSO4;NaFeEDTA;non-transferrin-bound iron (NTBI);developing countries;Indonesia;neurodegeneration;mitochondria;therapy;heme;haem;Iron-sulfur;Friedreich Ataxia;Oxidative stress;Iron chelators;iron deficiency;anemia;cancer;hepcidin;patient blood management;malaria;iron deficiency;hepcidin;TNF;children;Africa;Anemia;iron deficiency;oral iron salts;intravenous iron;Sucrosomial® iron;M cells;bioavailability;tolerability;efficacy;iron;gut microbiota;iron supplementation;iron transporters;mucosal immunity;SCFA;intestinal inflammation;inflammatory bowel disease (IBD);colorectal cancer;oxidative stress;anaemia;cardiovascular disease;chronic kidney disease;IV iron therapy;bone homeostasis;iron overload;iron deficiency;osteoclast;osteoblast;osteoporosis;neurodegeneration with brain iron accumulation;iron chelation therapy;multifunctional iron chelators;fluorescent iron chelator;3-hydroxy-4-pyridinone;fluorophore;rhodamine;membrane interactions;bacteria;antibacterial activity;histidine;iron;anemia;oxidative stress;kidney;chelation;iron;retina;age-related macular degeneration (AMD);iron;lipid;obesity;cancer;neurodegeneration;iron chelation;phlebotomy;NCOA4;ferritinophagy;iron homeostasis;erythropoiesis;ferroptosis;cancer;Tfr2;iron metabolism;hepcidin;erythropoiesis;SNC;ferritin;iron mobilization;chaotropes;flavin nucleotide;electron transfer;kinetics;ferritin;iron;iron delivery;nanotechnology;nanocage;drug delivery;inflammation;serum biomarker;iron metabolism;hepcidin;ferroportin;hemochromatosis;anemia;hepcidin;iron deficiency anemia;iron dextran;neonatal period;pig;supplementation;Alzheimer’s disease;neuroinflammation;neurodegeneration;cytokines;neuroimmune responses;iron;genetic hemochromatosis;non transferrin bound iron;hepcidin;ferroportin;venesections;Anemia of chronic disease;anemia of inflammation;hepcidin;anti-hepcidin therapy;iron supplementation;macrophage;central nurse macrophage;red pulp macrophage;Kupffer cell;iron metabolism;erythropoiesis;erythroblastic islands;erythrophagocytosis;inflammation;iron homeostasis;lung diseases;oxygen sensing;hypoxia;ferritin;hereditary hyperferritinemia;hereditary hypoferritinemia;iron metabolism;cataracts syndrome;neurodegenerative disease;n/a;iron;neurodegeneration;NBIA;hepcidin;iron;lung;acute lung injury;COPD;lung infection;cystic fibrosis;iron;anaemia;infection;malaria;immunity;brain development;growth;microbiome;hepcidin;ferritin;iron supplementation;infants;children;low and middle income countries;liver;iron;hepcidin;Mek/Erk;Hfe;Bmp/Smad;iron;mycobacteria;immunity;Alzheimer’s disease;iron homeostasis;ferroptosis;senescence;chelators;macrophages;iron;metabolism;inflammation;iron;ferritin;acute kidney injury;chronic kidney disease;vascular calcification;iron;hepcidin;ferroportin;Interleukin-6;infection;rheumatoid arthritis;iron homeostasis;iron absorption;non-haem iron;flavonoids;developmental;iron deficiency anemia;neonatal;transferrin receptor;treatment;hemochromatosis;HFE;natural history;T lymphocytes;MHC;CD8+ T cells;prevention;iron homeostasis;hepcidin;protein binding;peritoneal dialysis;iron;hepcidin;iron regulatory proteins;cardiomyocyte;chronic heart failure;pulmonary arterial smooth muscle cells;pulmonary arterial hypertension;iron;brain;neurophysiology;cognition;social behavior;didox;iron chelators;antitumor compound;iron metabolism;RRM2;SLC40A1;ferroportin;iron overload;non-HFE;ferritin;hemochromatosis;iron;chelation;neurodegenerative diseases;pituitary;brain;hemopexin;heme homeostasis;iron homeostasis;hemolysis;haptoglobin;ferroptosis;inflammation;biomarker;heme oxygenase;liver;microbiome;trauma;hemorrhage;iron metabolism;hepcidin;iron homeostasis;ferroportin;n/a |
| ISBN: | 9783319909554 |
| Theme: | 教科書-醫學類 |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.